These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2304893)

  • 1. Effects of amperozide, a putative antipsychotic drug, on rat midbrain dopamine neurons recorded in vivo.
    Grenhoff J; Tung CS; Ugedo L; Svensson TH
    Pharmacol Toxicol; 1990; 66 Suppl 1():29-33. PubMed ID: 2304893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the acute and chronic administration of the putative atypical antipsychotic drug Y-931 (8-fluoro-12- (4-methylpiperazin-1-yl)-6H-[1]benzothieno[2,3b][1,5] benzodiazepine maleate) on spontaneously active rat midbrain dopamine neurons: an in vivo electrophysiological study.
    Minabe Y; Hashimoto K; Shirayama Y; Ashby CR
    Synapse; 2004 Jan; 51(1):19-26. PubMed ID: 14579422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition.
    Ugedo L; Grenhoff J; Svensson TH
    Psychopharmacology (Berl); 1989; 98(1):45-50. PubMed ID: 2524859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The acute and chronic administration of the 5-HT(2B/2C) receptor antagonist SB-200646A significantly alters the activity of spontaneously active midbrain dopamine neurons in the rat: An in vivo extracellular single cell study.
    Blackburn TP; Suzuki K; Ashby CR
    Synapse; 2006 Jun; 59(8):502-12. PubMed ID: 16565966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kynurenate blocks the acute effects of haloperidol on midbrain dopamine neurons recorded in vivo.
    Tung CS; Grenhoff J; Svensson TH
    J Neural Transm Gen Sect; 1991; 84(1-2):53-64. PubMed ID: 2054150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burst firing of mesencephalic dopamine neurons is inhibited by somatodendritic application of kynurenate.
    Charlety PJ; Grenhoff J; Chergui K; De la Chapelle B; Buda M; Svensson TH; Chouvet G
    Acta Physiol Scand; 1991 May; 142(1):105-12. PubMed ID: 1877358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of acute and chronic administration of the selective 5-HT2C receptor antagonist SB-243213 on midbrain dopamine neurons in the rat: an in vivo extracellular single cell study.
    Blackburn TP; Minabe Y; Middlemiss DN; Shirayama Y; Hashimoto K; Ashby CR
    Synapse; 2002 Dec; 46(3):129-39. PubMed ID: 12325040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and chronic administration of the selective sigma1 receptor agonist SA4503 significantly alters the activity of midbrain dopamine neurons in rats: An in vivo electrophysiological study.
    Minabe Y; Matsuno K; Ashby CR
    Synapse; 1999 Aug; 33(2):129-40. PubMed ID: 10400891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine modulates midbrain dopamine neuron firing via interaction with the NMDA receptor complex.
    Schwieler L; Engberg G; Erhardt S
    Synapse; 2004 May; 52(2):114-22. PubMed ID: 15034917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of the acute and chronic administration of CP 96,345, a selective neurokinin1 receptor antagonist, on midbrain dopamine neurons in the rat: a single unit, extracellular recording study.
    Minabe Y; Emori K; Toor A; Stutzmann GE; Ashby CR
    Synapse; 1996 Jan; 22(1):35-45. PubMed ID: 8822476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 5-HT1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons.
    Arborelius L; Chergui K; Murase S; Nomikos GG; Höök BB; Chouvet G; Hacksell U; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Apr; 347(4):353-62. PubMed ID: 8510763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible mechanisms by which repeated clozapine administration differentially affects the activity of two subpopulations of midbrain dopamine neurons.
    Chiodo LA; Bunney BS
    J Neurosci; 1985 Sep; 5(9):2539-44. PubMed ID: 2863337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the acute and chronic administration of the selective 5-HT6 receptor antagonist SB-271046 on the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Minabe Y; Shirayama Y; Hashimoto K; Routledge C; Hagan JJ; Ashby CR
    Synapse; 2004 Apr; 52(1):20-8. PubMed ID: 14755629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The acute and chronic administration of (+/-)-8-hydroxy-2-(Di-n-propylamino)tetralin significantly alters the activity of spontaneously active midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Nakamura K; Suzuki K; McCreary AC; Ashby CR
    Synapse; 2006 May; 59(6):359-67. PubMed ID: 16463399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mode of action of atypical neuroleptics in relation to the phencyclidine model of schizophrenia: role of 5-HT2 receptor and alpha 1-adrenoceptor antagonism [corrected].
    Svensson TH; Mathé JM; Andersson JL; Nomikos GG; Hildebrand BE; Marcus M
    J Clin Psychopharmacol; 1995 Feb; 15(1 Suppl 1):11S-18S. PubMed ID: 7730496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel in vivo electrophysiological assay for the effects of cocaine and putative "cocaine antagonists" on dopamine transporter activity of substantia nigra and ventral tegmental area dopamine neurons.
    Hinerth MA; Collins HA; Baniecki M; Hanson RN; Waszczak BL
    Synapse; 2000 Dec; 38(3):305-12. PubMed ID: 11020233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GABA(B) receptor-mediated modulation of the firing pattern of ventral tegmental area dopamine neurons in vivo.
    Erhardt S; Mathé JM; Chergui K; Engberg G; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):173-80. PubMed ID: 11882912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotinic effects on the firing pattern of midbrain dopamine neurons.
    Grenhoff J; Aston-Jones G; Svensson TH
    Acta Physiol Scand; 1986 Nov; 128(3):351-8. PubMed ID: 3788613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of amperozide on rat cortical 5-HT2 and striatal and limbic dopamine D2 receptor occupancy: implications for antipsychotic action.
    Meltzer HY; Zhang Y; Stockmeier CA
    Eur J Pharmacol; 1992 May; 216(1):67-71. PubMed ID: 1388121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The atypical antipsychotic drug amperozide enhances rat cortical and striatal dopamine efflux.
    Pehek EA; Meltzer HY; Yamamoto BK
    Eur J Pharmacol; 1993 Aug; 240(1):107-9. PubMed ID: 8405119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.